Michael Calhoun has spent more than 20 years in the biopharmaceutical industry developing and executing rodent disease models for programs covering a wide range of pathologies including: Neurodevelopmental Disorders, Alzheimer’s Disease, Parkinson’s Disease, Stroke, Epilepsy, Pain, Schizophrenia, and Cardiovascular Disease.
